EyePoint Pharmaceuticals
EYPT
#8353
Rank
C$0.46 B
Marketcap
C$5.49
Share price
13.77%
Change (1 day)
-70.69%
Change (1 year)

Earnings for EyePoint Pharmaceuticals (EYPT)

Earnings in 2026 (TTM): -C$0.38 Billion

According to EyePoint Pharmaceuticals 's latest financial reports the company's current earnings are C$7.61 Million. In 2025 the company made an earning of -C$0.33 Billion a decrease over its 2024 earnings that were of -C$0.2 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for EyePoint Pharmaceuticals from 2003 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -C$0.38 Billion14.98%
2025 -C$0.33 Billion63.24%
2024 -C$0.2 Billion104.29%
2023 -C$97.15 Million-29.88%
2022 -C$0.14 Billion87.2%
2021 -C$74.01 Million38.58%
2020 -C$53.41 Million-24.56%
2019 -C$70.79 Million
2017 -C$32.29 Million22.59%
2016 -C$26.34 Million-8.02%
2015 -C$28.64 Million-296.09%
2014 C$14.6 M-174.02%
2013 -C$19.73 Million37.42%
2012 -C$14.36 Million-56.29%
2011 -C$32.84 Million-1062.38%
2010 C$3.41 M-250.43%
2009 -C$2.27 Million-89.5%
2008 -C$21.61 Million
2005 -C$13.33 Million56.99%
2004 -C$8.49 Million73.7%
2003 -C$4.89 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Nymox Pharmaceutical
NYMX
-C$3.03 Million-99.20% Bahamas
NRC Health
NRC
C$27.43 M-107.26%๐Ÿ‡บ๐Ÿ‡ธ USA